CD3CD20MBS303BI…
mbs303915cdembs303cd20cd3b mbs303tMBS303MSC303 (MBS303 as the intravenous formulation, MSC303 as the subcutaneous formulation) is an innovative CD20CD3 T-cell engager. MBS303 has initiated clinical trials
IDR 10.000
IDR 100.000
Disc -90%